Patterns of healthcare utilization in patients with generalized anxiety disorder in general practice in Germany

European Journal of Psychiatry

Volumn 23, Issue 2, 2009, Pages 90-100

  Berger, Ariel ^a   Dukes, Ellen ^b   Wittchen, Hans Ulrich ^c   Morlock, Robert ^b   Edelsberg, John ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

^b PFIZER INC   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Anxiety; Anxiety disorders; Healthcare research; Utilization

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; SEDATIVE AGENT;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIGESTIVE SYSTEM DISEASE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GENERALIZED ANXIETY DISORDER; GERMANY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRESCRIPTION; SLEEP DISORDER; SUBSTANCE ABUSE;

EID: 77955392754     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: 10.4321/S0213-61632009000200003     Document Type: Article

References (31)

1. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC: American Psychiatric Association; 1992.
2. Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6): 593-602.
3. Lieb R, Becker E, Altamura C. The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol European Neuropsychopharmacology 2005; 15(4): 445-452.
4. Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol 2000; 15(6): 319-328.
5. Ormel J, VonKorff M, Ustun T, Pini S, Korton A, Oldehinkel T. Common mental disorders and disability across cultures: Results from the WHO collaborative study on psychological problems in general health care. JAMA 1994; 272(22): 1741-1748.
6. Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety disorder and depression in primary care: Prevalence, recognition, and management. J Clin Psychiatry 2002; 63(Suppl 8): 24-34.
7. Monk-Jorgensen P, Allgulander C, Dahl AA, Foldager L, Holm M, Rasmussen IbIB, et al. Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psych Services 2006; 57(12): 1738-1744
8. Massion, A, Warshaw, M, Keller M,. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993; 150(4): 600-607.
9. Stein DJ. Comorbidity in generalized anxiety disorder: Impact and implications. J Clin Psychiatry 2001; 62(Suppl 11): S29-S34.
10. Wittchen HU, Zhao S, Kessler R, Eaton W. DSMIII- R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51(5): 355-364.
11. Carter CS, Maddock RJ. Chest pain in generalized anxiety disorder. Int J Psychiatry Med 1991; 22(3): 291-298.
12. Goodwin R, Stein M. Generalized anxiety disorder and peptic ulcer disease among adults in the United States. Psychosom Med 2002; 64(6): 862-866.
13. Grigsby A, Anderson R, Freedland K, Clouse R, Lustman P. Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res 2002; 53(6): 1053-1060.
14. Kane FJ Jr., Harper RG, Wittels E. Angina as a symptom of psychiatric illness. South Med J 1988; 81(11): 1412-1416.
15. Logue MB, Thomas AM, Barbee JG, Hoehn-Saric R, Maddock RJ, Schwab J, et al. Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder. J Psychiatr Res 1993; 27(1): 55-59.
16. Lydiard R. An overview of generalized anxiety disorder: Disease state-appropriate therapy. Clin Ther 2000; 22(Suppl A): S3-S24.
17. Lydiard R, Fossey, M, Marsh W, Ballenger J. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993(3); 34(3): 229-234.
18. Pearce M, Mayou R, Klimes I. The management of atypical non-cardiac chest pain. Q J Med 1990; 76(3): 991-996.
19. Roy-Byrne P, Wagner A. Primary care perspectives on general anxiety disorder. J Clin Psychiatry 2004; 65(Suppl 13): S20-S26.
20. Wittchen HU. Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety 2002; 16(4): 162-171.
21. Hoffman DL, Dukes EM,Wittchen HU. Human and economic burden of generalized anxiety disorder. Depress Anxiety 2006; 1(1): 1-19.
22. Belanger L, Ladouceur R, Morin CM. Generalized anxiety disorder and health care use. Can Fam Physician 2005; 51(10): 1362-1363.
23. Kennedy BL, Schwab JL. Utilization of medical specialists by anxiety disorder patients. Psychosomatics 1997; 38(2): 109-112.
24. Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, et al. The cost of treating anxiety: The medical and demographic correlates that impact total medical costs. Depress Anxiety Depression and Anxiety 2005; 21(4): 178-184.
25. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol European Journal of Neurology 2005; 12(Supp 1): S1-S27.
26. SAS® Proprietary Software, Release 8.4, SAS Institute Inc., Cary, NC.
27. Wulsin LR, Arnold LM, Hillard JR. Axis I disorders in ER patients with atypical chest pain. Int J Psychiatry Med 1991; 21(1): 37-46.
28. de Ruiter C, Garsson B, Rijken H, Kraaimaat F. The hyperventilation syndrome in panic disorder, agoraphobia and generalized anxiety disorder. Behav Res Ther 1989; 27(4): 447-452.
29. Maier W, Falkai P. The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol 1999; 14(Suppl 2): S1-S6.
30. Sherbourne CD, Jackson CA, Meredith LS, Camp P, Wells KB. Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 1996; 5(1): 27-34.
31. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JRT, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association of Psychopharmacology. J Psychopharm 2005; 19(6): 567-596.